Philip D. Noguchi
Food and Drug Administration
34 Papers
830 Citations
Philip D. Noguchi is an academic researcher from Food and Drug Administration. The author has contributed to research in topics: Antigen & Monoclonal antibody. The author has an hindex of 18, co-authored 34 publications.
Chat about Author
Papers
•Journal Article
Generation and Characterization of B72.3 Second Generation Monoclonal Antibodies Reactive with the Tumor-associated Glycoprotein 72 Antigen
Raffaella Muraro,Masahide Kuroki,D. Wunderlich,Diane J. Poole,David Colcher,A. Thor,John W. Greiner,Jean F. Simpson,Alfredo A. Molinolo,Philip D. Noguchi +9 more
TL;DR: It is demonstrated that one or more of the anti-TAG-72 CC MAbs may be more efficient than B72.3, or useful in combination with B72,3, toward the further study of human carcinoma cell population and the diagnostic and therapeutic procedures presently utilizing MAb B 72.3.
246
•Journal Article
Influence of Spatial Configuration of Carcinoma Cell Populations on the Expression of a Tumor-associated Glycoprotein
TL;DR: Spatial configuration of carcinoma cell populations is shown to influence the expression of a tumor-associated antigen and the subsequent surface binding of monoclonal antibody B72.3.
138
Risks and benefits of gene therapy.
TL;DR: Although most of today's gene-therapy trials are clinical trials, there is no consensus on whether these trials should be conducted on animals or on humans.
67
Prenatal gene transfer: Scientific, medical, and ethical issues: A report of the recombinant DNA advisory committee
R S Mc Ivor,Dale Ando,Xandra O. Breakefield,Rebecca H. Buckley,Louise T. Chow,Albert B. Deisseroth,Jay J. Greenblatt,Claudia A. Mickelson,M. Louise Markert,Estuardo Aguilar-Cordova,Alan R. Cohen,John C. Fletcher,Evelyn Karson,Robertson Parkman,Jon A. Wolff,Doris T. Zallen,Nancy M. P. King,Ruth Macklin,Lori Andrews,Theodore Friedmann,Jon W. Gordon,Eric T. Juengst,Sue L. Levi-Pearl,Melody H. Lin,R. Scott McIvor,Philip D. Noguchi +25 more
63
Oligodeoxyribonucleotide phosphorothioate fluxes and localization in hematopoietic cells.
TL;DR: An antisense oligon nucleotide phosphorothioate, previously shown to inhibit HIV-1 viral expression in chronically infected H9 cells, was fluorescently labeled to study oligonucleotide fluxes and localization within living cells.
62